
Daniel M. Sullivan
Director (ID: 14769, Phone: (571)272-0900 , Office: P/1600 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1600, 1621, 1636, 1611 |
| Total Applications | 676 |
| Issued Applications | 156 |
| Pending Applications | 227 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18707581
[patent_doc_number] => 20230330158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE
[patent_app_type] => utility
[patent_app_number] => 17/915610
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915610 | INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE | Jun 23, 2020 | Abandoned |
Array
(
[id] => 17808721
[patent_doc_number] => 20220260556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SALIVA TESTING
[patent_app_type] => utility
[patent_app_number] => 17/624333
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624333 | SALIVA TESTING | Jun 22, 2020 | Abandoned |
Array
(
[id] => 18226820
[patent_doc_number] => 20230065814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/596831
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 700
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596831 | CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS | Jun 18, 2020 | Pending |
Array
(
[id] => 17895467
[patent_doc_number] => 20220305129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => CONJUGATES OF HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/596833
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 315
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596833 | CONJUGATES OF HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS | Jun 18, 2020 | Pending |
Array
(
[id] => 17805715
[patent_doc_number] => 20220257550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR DHA
[patent_app_type] => utility
[patent_app_number] => 17/625295
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625295 | REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR DHA | Jun 15, 2020 | Abandoned |
Array
(
[id] => 17838024
[patent_doc_number] => 20220275329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITIONS AND METHODS FOR MATURING STEM CELL-DERIVED BETA CELLS
[patent_app_type] => utility
[patent_app_number] => 17/616993
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616993 | COMPOSITIONS AND METHODS FOR MATURING STEM CELL-DERIVED BETA CELLS | Jun 7, 2020 | Pending |
Array
(
[id] => 17895395
[patent_doc_number] => 20220305057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHODS OF MAKING CELLULAR PRODUCTS BY POST- MORTEM MOBILIZATION AND HARVESTING OF HEMATOPOIETIC CELLS
[patent_app_type] => utility
[patent_app_number] => 17/616869
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616869 | METHODS OF MAKING CELLULAR PRODUCTS BY POST- MORTEM MOBILIZATION AND HARVESTING OF HEMATOPOIETIC CELLS | Jun 1, 2020 | Abandoned |
Array
(
[id] => 17760014
[patent_doc_number] => 20220233626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => GRAPE PERICARP EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/595842
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595842 | GRAPE PERICARP EXTRACT | May 21, 2020 | Abandoned |
Array
(
[id] => 17748000
[patent_doc_number] => 20220226203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SKIN-ATTACHABLE THIN FILM PATCH BASED ON A WATER-SOLUBLE NON-WOVEN FABRIC
[patent_app_type] => utility
[patent_app_number] => 17/612937
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612937 | SKIN-ATTACHABLE THIN FILM PATCH BASED ON A WATER-SOLUBLE NON-WOVEN FABRIC | May 20, 2020 | Abandoned |
Array
(
[id] => 17718976
[patent_doc_number] => 20220211695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MORPHINE-INDUCED RESPIRATORY DEPRESSION: BEHAVIORAL, PHRENIC AND BRAINSTEM RESPIRATORY NEURONAL EVIDENCE
[patent_app_type] => utility
[patent_app_number] => 17/612152
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612152 | MORPHINE-INDUCED RESPIRATORY DEPRESSION: BEHAVIORAL, PHRENIC AND BRAINSTEM RESPIRATORY NEURONAL EVIDENCE | May 17, 2020 | Abandoned |
Array
(
[id] => 17705976
[patent_doc_number] => 20220205982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS FOR DETERMINING PERSONALIZED FULL DOSE OF MELPHALAN IN REDUCED INTENSITY REGIMEN PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 17/611398
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611398
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611398 | METHODS FOR DETERMINING PERSONALIZED FULL DOSE OF MELPHALAN IN REDUCED INTENSITY REGIMEN PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION | May 14, 2020 | Abandoned |
Array
(
[id] => 17790285
[patent_doc_number] => 20220249376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => NANOVESICLES AND ITS USE FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/610971
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610971 | NANOVESICLES AND ITS USE FOR NUCLEIC ACID DELIVERY | May 11, 2020 | Pending |
Array
(
[id] => 17656931
[patent_doc_number] => 20220177396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => PROCESS FOR THE SEPARATION OF PINITOL FROM A CAROB EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/607143
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607143 | PROCESS FOR THE SEPARATION OF PINITOL FROM A CAROB EXTRACT | Apr 29, 2020 | Pending |
Array
(
[id] => 17721612
[patent_doc_number] => 20220214334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => METHODS TO IMPROVE DETECTION OF GLYCOSYLAMINES
[patent_app_type] => utility
[patent_app_number] => 17/606915
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606915 | METHODS TO IMPROVE DETECTION OF GLYCOSYLAMINES | Apr 29, 2020 | Pending |
Array
(
[id] => 18075963
[patent_doc_number] => 20220401575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONALLY DEFINED PLASMID DNA/POLYCATION NANOPARTICLES AND METHODS FOR MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/606605
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606605 | COMPOSITIONALLY DEFINED PLASMID DNA/POLYCATION NANOPARTICLES AND METHODS FOR MAKING THE SAME | Apr 28, 2020 | Pending |
Array
(
[id] => 17880364
[patent_doc_number] => 20220295841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PLANT-DERIVED SCAFFOLDS FOR GENERATION OF SYNTHETIC ANIMAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/603695
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603695 | PLANT-DERIVED SCAFFOLDS FOR GENERATION OF SYNTHETIC ANIMAL TISSUE | Apr 16, 2020 | Pending |
Array
(
[id] => 17719152
[patent_doc_number] => 20220211871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => GENE THERAPIES FOR LYSOSOMAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/601984
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601984 | GENE THERAPIES FOR LYSOSOMAL DISORDERS | Apr 9, 2020 | Abandoned |
Array
(
[id] => 17627546
[patent_doc_number] => 20220162561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COMPOSITION FOR PROMOTING SECRETION OF EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/601076
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601076
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601076 | COMPOSITION FOR PROMOTING SECRETION OF EXTRACELLULAR VESICLES | Apr 2, 2020 | Abandoned |
Array
(
[id] => 17593648
[patent_doc_number] => 20220143221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Gene Therapy For Eye Pathologies
[patent_app_type] => utility
[patent_app_number] => 17/600377
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600377 | Gene Therapy For Eye Pathologies | Apr 1, 2020 | Pending |
Array
(
[id] => 17670995
[patent_doc_number] => 20220184162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/598426
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598426 | PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN TREATING CANCER | Mar 26, 2020 | Abandoned |